Alembic
106.80
+0.97(+0.92%)
Market Cap₹2,742.43 Cr
PE Ratio8.56
IndustryRealty
Company Performance:
1D+0.92%
1M-9.87%
6M+11.11%
1Y-29.43%
5Y+29.06%
View Company Insightsright
Latest news about Alembic
Alembic Pharma Secures USFDA Approval for Tretinoin Cream 0.025% 2 days ago
Alembic Pharmaceuticals has received final approval from the USFDA for Tretinoin Cream 0.025%, a topical medication used in dermatology. This approval allows the company to market and distribute the product in the United States, potentially expanding its dermatological portfolio and strengthening its position in the U.S. pharmaceutical market. The approval is expected to contribute to revenue growth and enhance Alembic's market presence.
Alembic Reports Q1 Profit Growth Amid Revenue Dip; Announces Leadership Changes 5 days ago
Alembic Pharma Reports 15% Jump in Q1 Net Profit, Revenue Grows 10% Aug 05, 2025
Alembic Pharma Secures USFDA Approval for Carbamazepine Extended Release Tablets Jul 26, 2025
Alembic Reports Q4 Profit Growth and Announces Dividend May 13, 2025